Recommended Dose Range News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Recommended Dose Range. Real-time updates on events, politics, business and more.

Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC

October 31, 2023

/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation,...

United Kingdom South Korea Kyonggi Do Republic Of Korea South Korean James Lee

Source: prnewswire.com

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

April 24, 2023

/PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea and Cambridge that is advancing novel drugs for...

United States United Kingdom South Korea Kyonggi Do Republic Of Korea James Lee

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Recommended Dose Range News Today

Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

Explore More Categories